DETERMINATION OF THE CLINICAL-NEUROLOGICAL CHARACTERISTICS OF MULTIPLE SCLEROSIS AND THE RELATIONSHIP OF S-100 OXIDE AND LIPOPROTEIDS
Keywords:
Keywords. 100 proteins, sclerosis, dysmetabolic process, multiple sclerosis.Abstract
Abstract. It remains urgent to carry out scientific research on the identification of pathogenetic factors in the development of multiple sclerosis , clinical-neurological features, clinical forms of the disease, course, gender ratio . In particular, it is important to determine S-100 protein levels and lipoprotein metabolism, factors affecting degeneration and demyelination, and the role of lipoprotein metabolism in the degeneration process in multiple sclerosis.
References
Yakubova M.M., Mukhiddinova M.A. Determination of activity and degree of invalidization of patients at the stage of diffuse sclerosis/Materialy conference Journal of Neurology Tashkent, 2018. - No. 4. - S.-100 (14.00.00, #4).
Yakubova M.M., Mukhiddinova M.A. Rol neurospetsificheskogo belka s-100 pri razvitii rasseyannogo sklerosa/Report conference. Journal Neurology Tashkent, 2019. - #4. - S.-103-104 (14.00.00, #4).
Yakubova MM, Mukhiddinova MA, Parpiyeva YR Dependence of indicators of quality of life of patients with multiple sclerosis from the degree of disabilities Postrnyy doklad //Uluslararasi Turk DunyasiMultiple Sclerosis Kongresi International Turkic World Congress of Multiple Sclerosis Abstracts book. Turkey, 2019. pp-14
Mukhiddinova MA The value of neuro-specific protein S-100 and lipoproteins in the development of multiple sclerosis/ Materialy konferentsii For participating in the international scientific and practical conference USA, September 2020 pp72-74
Michetti F., Gazzolo D. S100B protein in biological fluids: a tool for perinatal medicine //Clinical Chemistry. - 2002. - T. 48. – no. 12. - S. 2097-2104.
Valentina, I. "Biomarkers in Multiple Sclerosis: Analysis of the Present Advantages and Look to the Future." J Psychol Neurosci 5.3 (2023): 1-14.
